证券代码：833429 证券简称：康比特 公告编号：2025-030 北京康比特体育科技股份有限公司 2024 年度独立董事述职报告（付立家） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载，误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 作为北京康比特体育科技股份有限公司（以下简称"公司"）的独立董事， 2024 年度本人严格按照《中华人民共和国公司法》、《中华人民共和国证券法》、 《北京证券交易所股票上市规则（试行）》、《北京证券交易所上市公司持续监管 指引第 1 号——独立董事》等相关规定，诚实、勤勉、独立地履行职责，积极出 席相关会议，认真审议董事会各项议案，切实维护公司和公众股东的合法权益， 促进公司规范运作，充分发挥了独立董事的作用。现将本人在 2024 年度工作情 况进行汇报如下： 一、会议出席情况 2024 年度，本人积极参加了公司召开的董事会，认真审阅相关资料，参与各 项议题的讨论并提出合理建议，以严谨的态度行使表决权，履行了独立董事的义 务。本年度出席董事会及列席股东大会会议情况如下： | 独立董 | 应出席 | 实际出 | 现场 ...

Financial Performance - Operating revenue for the first quarter of 2025 reached CNY 193,752,584.37, representing a year-on-year increase of 26.08%[11] - Net profit attributable to shareholders for the first quarter of 2025 was CNY 12,036,941.28, up 9.66% from the same period last year[11] - Total revenue for Q1 2025 reached ¥193,752,584.37, a significant increase from ¥153,676,683.10 in Q1 2024, representing a growth of approximately 26%[42] - Net profit for Q1 2025 reached CNY 12,036,709.84, an increase of 9.5% compared to CNY 10,995,156.82 in Q1 2024[43] - Basic and diluted earnings per share for Q1 2025 were both CNY 0.10, compared to CNY 0.09 in Q1 2024, indicating a 11.1% increase[44] - Total comprehensive income for Q1 2025 was CNY 12,036,709.84, compared to CNY 10,995,156.82 in Q1 2024, marking a growth of 9.5%[45] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 117,262,155.18, a significant decline of 322.16% compared to the previous year[11] - Cash inflow from operating activities in Q1 2025 was CNY 168,207,462.98, slightly up from CNY 167,865,939.47 in Q1 2024[46] - The net cash flow from operating activities was -117,262,155.18 yuan, compared to -27,776,476.13 yuan in the previous year, indicating a significant decline in operational performance[47] - Total cash inflow from operating activities was 198,188,870.74 yuan, while cash outflow was 242,008,072.68 yuan, resulting in a net cash flow of -43,819,201.94 yuan for the current period[48][49] - The ending cash and cash equivalents balance was 307,223,402.68 yuan, down from 343,713,408.93 yuan year-over-year[47] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 1,171,324,695.19, a decrease of 0.69% compared to the end of the previous year[11] - The company's total liabilities as of March 31, 2025, were RMB 314,708,949.37, compared to RMB 320,627,164.03 at the end of 2024[37] - The company's current assets totaled RMB 754,981,365.53, slightly down from RMB 760,988,526.04 at the end of 2024[35] - Total liabilities decreased to ¥219,484,431.03 as of March 31, 2025, down from ¥246,776,215.36 as of December 31, 2024, reflecting a decline of about 11%[41] Shareholder Information - The total number of ordinary shareholders was 5,716 as of the end of the reporting period[18] - The largest shareholder, Beijing Huikang Information Consulting Center, holds 28,461,255 shares, representing 22.86% of total shares[20] - The total shares held by the top ten shareholders amount to 74,890,742, which is 60.15% of the total shares[20] - The company has no pledged or judicially frozen shares among the top shareholders[21] Research and Development - Research and development expenses for Q1 2025 were ¥8,612,602.44, compared to ¥7,460,042.17 in Q1 2024, representing an increase of approximately 15%[42] - Research and development expenses for Q1 2025 amounted to CNY 6,775,364.99, an increase from CNY 5,974,323.69 in Q1 2024, reflecting a growth of 13.4%[44] Share Repurchase and Equity Plans - The company repurchased shares, resulting in treasury stock increasing by 191.90% to CNY 21,773,789.03[13] - The company approved a share repurchase plan with a budget of no less than RMB 10 million and no more than RMB 20 million, with a maximum repurchase price of RMB 13 per share[28] - As of December 31, 2024, the company repurchased 567,746 shares, accounting for 0.46% of the total share capital, with a total expenditure of RMB 5,680,553.06, which is 28.40% of the planned repurchase budget[28] - The maximum repurchase price was adjusted to RMB 25 per share, and the implementation period was extended to March 25, 2025[29] Commitments and Legal Matters - The company has not engaged in any litigation, arbitration, or external guarantees during the reporting period[23] - There are no significant related party transactions or fund misappropriation issues reported[23] - The company has disclosed commitments and has fulfilled them as per the prospectus[24] - The company has ongoing commitments that are being fulfilled as disclosed previously[31]

Product Innovation and Development - In 2024, Kangbiter launched new weight management products and upgraded its whey protein ultra product, winning the "Nutritional Food Technology Innovation Award" at the IWF Shanghai International Fitness Expo[8]. - Kangbiter's whey protein ultra product received widespread recognition, winning the 2024 Global Food Innovation Award bronze medal[9]. - The company is focusing on product innovation, launching the CPT pro specialized nutrition formula whey protein to enhance protein absorption efficiency[49]. - The company has completed the development of white kidney bean extract tablets, targeting consumers who enjoy carbohydrates but are concerned about weight management[95]. - The development of a CLA fish oil fat-reducing beverage has been completed, with successful sensory testing[95]. - The company has achieved batch production of slow-release creatine tablets, expanding its market presence among fitness enthusiasts[95]. - The company has successfully developed a range of ready-to-eat foods, including fried rice and chicken sticks, with plans for mass production and sales[96]. - The company has completed the industrialization of biscuit products, addressing issues related to microbial contamination and improving taste[96]. - The company is in the process of developing a new type of puffed protein bar, focusing on texture and stability improvements[96]. - The company has optimized the production process for energy gels, transitioning from contract manufacturing to in-house production, reducing costs[95]. - The company is developing a high-efficiency peptide drink aimed at post-exercise recovery, with a shelf life of over 12 months[104]. Financial Performance - The company's revenue for 2024 reached ¥1,040,013,192.71, representing a 23.34% increase compared to ¥843,220,191.54 in 2023[31]. - The net profit attributable to shareholders for 2024 was ¥89,313,991.99, a slight increase of 1.38% from ¥88,101,313.18 in 2023[31]. - The gross profit margin for 2024 decreased to 39.41% from 40.09% in 2023[31]. - Total assets at the end of 2024 amounted to ¥1,179,520,735.98, reflecting a 10.34% increase from ¥1,068,961,077.66 at the end of 2023[32]. - The company's total liabilities increased by 18.20% to ¥320,627,164.03 in 2024 from ¥271,250,624.62 in 2023[32]. - The return on equity (ROE) based on net profit attributable to shareholders was 10.76% in 2024, down from 11.50% in 2023[31]. - The company's cash flow from operating activities for 2024 was ¥132,159,732.23, a decrease of 10.83% from ¥148,208,544.00 in 2023[32]. - The accounts receivable turnover ratio improved to 14.84 in 2024 from 11.41 in 2023[33]. - The inventory turnover ratio increased to 3.02 in 2024, compared to 2.82 in 2023[33]. - The company's debt-to-asset ratio (consolidated) was 27.18% in 2024, up from 25.38% in 2023[32]. - The total profit for 2024 is ¥102,713,973.86, showing a minor difference of -0.10% from the earnings forecast[34]. Market Position and Recognition - The company was awarded the "Annual High Growth Award" on the Tmall health platform, leading the health track in the domestic health product industry[8]. - Kangbiter was listed in the "2024 Beijing Manufacturing Enterprises Top 100" and "2024 Beijing Specialized and Innovative Enterprises Top 100," reflecting its recognition in promoting high-quality economic development[10]. - The company established a digital sports health nutrition industry integration community with Beijing Sport University and Guangzhou City Vocational College[7]. - The company achieved a "Five-Star Credit Rating" in the corporate credit rating assessment, showcasing its strong corporate strength and credibility[9]. - The company is positioned in the rapidly growing sports nutrition food industry, with significant market potential due to low product penetration and increasing consumer awareness[53]. - The global sports nutrition market size grew from 16.314 billion USD in 2017 to 18.56 billion USD in 2022, and is projected to reach 25.191 billion USD by 2026[56]. Corporate Governance and Management - The company has established a robust governance structure, ensuring compliance with relevant laws and regulations[178]. - The board of directors consists of 7 members, while the supervisory board has 3 members and there are 6 senior management personnel[158]. - The company has implemented a performance evaluation mechanism for senior management, linking their compensation to performance indicators[198]. - The company maintains independence in operations, personnel, assets, institutions, and finances, ensuring no conflicts with shareholders[194]. - The supervisory board confirmed that the board of directors operated in compliance with resolutions from shareholder meetings, with no major risks identified[193]. Research and Development - The company maintains a robust R&D model, focusing on self-developed products and structured project management[42]. - The procurement system is designed to ensure quality through a multi-level evaluation mechanism for suppliers[43]. - The company applied for 38 patents in 2024, including 3 invention patents, and currently holds 198 authorized patents, comprising 103 invention patents, 60 utility model patents, and 35 design patents[52]. - The total number of R&D personnel decreased slightly to 100, with a proportion of 12.7% of total employees[92]. Strategic Partnerships and Collaborations - The company engaged in deep cooperation discussions with JD Health and Tmall Health to promote the healthy development of the sports nutrition industry[9]. - The company has established partnerships with universities to accelerate technological innovation in the sports nutrition sector[52]. Employee and Shareholder Information - The total number of employees increased from 795 to 901, representing a growth of approximately 13.3%[167]. - The company has a stock incentive plan with 710,000 shares that are currently unexercised[166]. - The company has repurchased 1,366,126 shares, accounting for 1.10% of the total share capital, and spent approximately 19.99 million yuan on this buyback[174]. - The largest shareholder, Beijing Huikang Information Consulting Center, holds 22.86% of the company’s shares, totaling 28,461,255 shares[138]. Risks and Challenges - The company acknowledges significant uncertainties in achieving its 2025 operational goals due to macroeconomic conditions and market demand fluctuations[109]. - The company faces risks related to actual control by major shareholders, which could impact strategic decisions and shareholder interests[110]. - The company recognizes competitive risks from both domestic and international brands in the expanding sports nutrition market[111].

Financial Performance - The company reported a basic earnings per share of 0.1000 yuan for Q1 2025, an increase of 11.11% compared to 0.0900 yuan in Q1 2024 [1] - The total revenue for Q1 2025 was 1.94 billion yuan, reflecting a growth of 25.97% from 1.54 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 was 0.12 billion yuan, which is a 9.09% increase from 0.11 billion yuan in Q1 2024 [1] - The return on equity (ROE) for Q1 2025 was 1.39%, slightly up from 1.37% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 64.55 million shares, accounting for 56.97% of the circulating shares, with a change of 162,700 shares from the previous period [1] - Beijing Huilikang Information Consulting Center (Limited Partnership) remains the largest shareholder with 28.46 million shares, representing 25.12% of the total share capital [2] - Notable changes include a decrease of 101.20 million shares held by Yin Hui International Limited and a decrease of 124.00 million shares held by Chen Qingyue [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]

Core Insights - 康比特智慧营养健康餐厅 launched at the 33rd Shanghai International Hotel and Catering Industry Expo, showcasing its "AI Sports Nutritionist" app integrated with DeepSeek model, aligning with the national "Weight Management Year" initiative [1][8] - The restaurant emphasizes personalized nutrition management based on individual health goals, addressing common health issues such as weight loss, muscle gain, and high uric acid levels [3][5] - 康比特's AI platform offers a balanced approach to nutrition and exercise, allowing users to offset excess calorie intake through exercise recommendations, promoting individualized health management [5][7] Industry Trends - The integration of AI technology in dietary services marks a shift from traditional methods to digital solutions, enhancing the quality of nutrition services for both athletes and the general public [8][10] - 康比特's initiative represents a new paradigm in employee welfare, where companies invest in health through digitalized canteen services, enabling employees to manage their health autonomously [10][12] - The use of professional body composition analysis tools at the expo highlights the importance of data-driven personalized nutrition services, which are crucial for effective health management [12][14] Product Features - 康比特智慧营养健康餐厅 offers AI nutrition advice, smart health management, and personalized nutrition reports, attracting significant industry attention [14] - The restaurant's immersive dining experience allows guests to engage with AI-driven meal planning, showcasing the potential for deeper integration of technology in the food service industry [14]

证券代码：833429 证券简称：康比特 公告编号：2025-015 北京康比特体育科技股份有限公司 回购股份达到 1%暨回购股份结果公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、 回购方案基本情况 （一） 审议情况 北京康比特体育科技股份有限公司（以下简称"公司"）于 2024 年 8 月 26 日召 开第六届董事会第七次会议、第六届监事会第七次会议，审议通过《关于公司回购股 份方案的议案》；公司于 2025 年 2 月 10 日召开第六届董事会第十次会议，审议通过 了《关于调整股份回购价格上限及延长实施期限的议案》。根据《北京证券交易所上 市公司持续监管指引第 4 号——股份回购》《公司章程》等相关规则制度规定，前述 事项均无需提交股东大会审议。 （二） 回购股份的目的 基于对公司未来发展的信心和对公司价值的认可，提升公司股票长期投资价值， 综合考虑公司经营情况、财务状况以及未来的盈利能力等因素，公司拟以自有资金回 购公司股份。本次回购的股份将用于实施股权激励，以此进一步完善公司治理结构 ...

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The recent signing of marathon runner Jiaorenjia as a brand ambassador is expected to enhance brand recognition and consumer trust, potentially driving sales [7] - The marathon industry in China is experiencing significant growth, with an increase in the number of events and participants, supported by favorable policies [7] - The company is actively developing a comprehensive product matrix to cater to runners' needs, including energy supplements and recovery products [7] - The company is building a running ecosystem to foster customer loyalty and encourage repeat purchases through sponsorship of events and partnerships with running groups [7] - The financial forecasts for the company remain stable, with projected net profits of 0.89 billion, 1.15 billion, and 1.56 billion for 2024, 2025, and 2026 respectively, indicating strong growth potential [7] Financial Data and Profit Forecast - Total revenue is projected to grow from 843 million in 2023 to 1,873 million by 2026, with a compound annual growth rate (CAGR) of approximately 33.2% [3] - The net profit attributable to the parent company is expected to increase from 88 million in 2023 to 156 million in 2026, reflecting a CAGR of around 35.1% [3] - Earnings per share (EPS) is forecasted to rise from 0.71 in 2023 to 1.25 in 2026 [3] Market Data - As of March 26, 2025, the closing price of the stock is 19.09, with a price-to-earnings (PE) ratio of 27 [4] - The company has a market capitalization of 2,163 million [4] - The stock has a dividend yield of 1.05% based on the most recent dividend announcement [4]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The weight management industry is identified as a golden growth track, with significant potential driven by increasing health consciousness and supportive policies [6][11] - The company is strategically positioning itself to capitalize on the booming weight management sector, aiming to establish it as a third growth pillar alongside its existing business lines [6][11] - The report slightly raises profit forecasts for 2024-2026, reflecting positive business developments and market conditions [6] Financial Data and Profit Forecast - Total revenue projections are as follows: 2023: 843 million, 2024E: 1,041 million, 2025E: 1,406 million, 2026E: 1,873 million, with growth rates of 32.8%, 23.4%, 35.0%, and 33.2% respectively [5] - Net profit forecasts are: 2024E: 89 million, 2025E: 115 million, 2026E: 156 million, with growth rates of 1.6%, 28.7%, and 35.1% respectively [5] - Earnings per share are projected to be 0.72, 0.93, and 1.25 for 2024E, 2025E, and 2026E respectively [5] - The price-to-earnings ratio is expected to be 26, 20, and 15 for the years 2024E, 2025E, and 2026E respectively [5] Industry Insights - The weight management sector is characterized by a large domestic consumer base and strong demand, with projections indicating that the number of overweight/obese individuals in China will exceed 500 million by 2030 [6][12] - The report highlights the increasing trend of health-conscious consumption among younger demographics, particularly women, who are prioritizing fitness and wellness [20][21] - The company is launching a new sub-brand, CPTfit, targeting the female market with a focus on high-protein products, which aligns with current consumer trends [6][11] Policy and Market Dynamics - The government is actively promoting weight management initiatives, with a national plan set to enhance public awareness and improve lifestyle habits [51][54] - The report draws parallels with Japan's weight management industry, emphasizing the role of government support in fostering market growth and innovation [54][56]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Insights - The company reported a revenue of 1.041 billion yuan for 2024, representing a year-on-year growth of 23.44%, and a net profit attributable to shareholders of 89.5 million yuan, which is a 1.59% increase year-on-year [4] - The company is focusing on high-end, differentiated competition, leveraging its brand, technology research and development, and sales channels to create value [4] - The forecast for net profit attributable to shareholders for 2024-2026 is adjusted to 89 million, 123 million, and 142 million yuan respectively, with corresponding EPS of 0.72, 0.99, and 1.14 yuan per share [4] Financial Performance Summary - Revenue for 2024 is projected at 1.041 billion yuan, with a year-on-year growth rate of 23.5% for 2025 and 21.7% for 2026 [5][10] - The net profit attributable to shareholders is expected to be 89 million yuan in 2024, 123 million yuan in 2025, and 142 million yuan in 2026, with year-on-year growth rates of 37.7% and 14.8% respectively [5][10] - The gross margin is projected to be 39.8% in 2024, improving to 40.8% in 2025 and 40.9% in 2026 [10][11] - The company plans to increase its participation in various outdoor events to enhance brand visibility and consumer loyalty [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][4] Core Insights - The company reported a revenue of 1.041 billion yuan for 2024, representing a year-on-year growth of 23.44%, and a net profit attributable to shareholders of 89.5 million yuan, which is a 1.59% increase year-on-year [4][5] - The company is focusing on high-end, differentiated competition, leveraging its brand, technology research and development, and sales channels to create value [4] - The forecast for net profit attributable to shareholders for 2024-2026 is adjusted to 89 million, 123 million, and 142 million yuan respectively, with corresponding EPS of 0.72, 0.99, and 1.14 yuan per share [4][5] Financial Performance Summary - Revenue and net profit projections for 2024-2026 are as follows: - Revenue: 1.041 billion (2024), 1.248 billion (2025), 1.518 billion (2026) - Net profit: 89 million (2024), 123 million (2025), 142 million (2026) - Year-on-year growth rates for revenue are projected at 23.5% (2024), 19.8% (2025), and 21.7% (2026) [5][10] - The company’s gross margin is expected to be around 39.8% in 2024, with a slight increase to 40.8% in 2025 and 40.9% in 2026 [10][11] Market Strategy - The company plans to increase sponsorship of outdoor events such as cycling, hiking, and team sports to enhance brand visibility and consumer loyalty [6] - The strategy includes linking events with e-commerce promotions to drive product sales effectively [6]